SARS-CoV-2 Spike RBD, mammalian recombinant

Cat.# 8COV1

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

Price:
-- / unit
* All prices excluding VAT
Request an offer Samples available
Infectious diseases
  • Cat.#

    8COV1

  • Source:

    Expressed in a mammalian cell line

  • Description:

    Spike RBD (receptor-binding domain) is a fragment Arg319-Phe541 of SARS-CoV-2 Spike surface glycoprotein [Severe acute respiratory syndrome coronavirus 2] GenBank: QHD43416.1.

    Contains C-terminal His6-tag.

    Theoretical MW 25921 Da including His6-tag.

    Theoretical pI: 8.91.

  • Applications:

    Antigen for detection of anti-(SARS-CoV-2 Spike RBD) antibodies

  • Analysis:

    Purity > 95%

    Concentration is determined spectrophotometrically at A280 using extinction coefficient 1.3.

  • Purification:

    Metal affinity chromatography

  • Presentation:

    Lyophilized from PBS, pH 7.4

    It is recommended to reconstitute this product with deionized water to its initial concentration.

  • Storage:

    Lyophilized at -20°C (-15 … -30 °C allowed)

    Reconstituted at -70°C (-65 … -80 °C allowed)

  • Other information:

    Avoid repeated freezing and thawing. It is recommended to aliquot the product after reconstitution.

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

×

Bulk Price Quotation

SARS-CoV-2 Spike RBD, mammalian recombinant (MAb: )

Information

×

Sample Request

SARS-CoV-2 Spike RBD, mammalian recombinant (MAb: )

Evaluation samples available. You can save up to 50%*

Information

*The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!